trending Market Intelligence /marketintelligence/en/news-insights/trending/0KsgTx1rzLuNGNDpVySBDg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Pernix Therapeutics CFO to depart

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Pernix Therapeutics CFO to depart

Pernix Therapeutics Holdings Inc.'s President and CFO Graham Miao will leave the company at the end of the year to pursue other opportunities.

Miao will provide support to the company during a transition period. Pernix said his resignation does not reflect any disagreement with the company's financial results or strategy for growth.

The company will immediately start a search to identify Miao's successor.

Miao has served as president and CFO of Pernix since July 2016.